Elastomeric infusion pumps are non-electronic medication pumps also called as balloon pumps which are used for infusion of analgesics, chemotherapy drugs, local anesthetics, antibiotics and other type of medications. Elastomeric infusion pumps are single use medical devices used for drug infusion. The process of infusion is carried out with the help of consistent pressure created in the elastomeric layer present in the pump which is controlled with the help of flow restrictors located in the elastomeric reservoir.

Market Dynamics

Increase in the prevalence of chronic diseases like cancer is expected to propel growth of market. For instance, according to factsheet published by World Health Organization (WHO) on 3 February, 2022, nearly 10 million deaths, or nearly one in six deaths were caused by cancer in 2020, making it the leading cause of death globally. Breast, lung, colon, rectum, and prostate cancers are the most prevalent types of cancer. In addition, according to WHO, each year, approximately 400,000 children develop cancer. Thus due to prevalence of cancer the global elastomeric infusion pumps market is expected grow over the forecast period.

Moreover, elastomeric infusion pumps are cheaper and have fewer adverse effects compared to electronic pumps, which increases their adoption in ambulatory chemotherapy infusion centers. Moreover, as elastomeric infusion pumps do not require electricity to operate, the risk for free flow of medication to patients is eliminated. Such advantages of elastomeric infusion pumps over their electric counterparts is also expected to boost growth of market.  

Key features of the study:

• This report provides in-depth analysis of the global elastomeric infusion pumps market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global elastomeric infusion pumps market  based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include B. Braun Melsungen AG, Fresenius Kabi, Leventon, S.A.U, Ambu A/S, Baxter International Inc., Halyard Health, and Nipro Corporation
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global elastomeric infusion pumps market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global elastomeric infusion pumps market

Detailed Segmentation:

• Global Elastomeric Infusion Pumps Market, By Product Type
  • Variable Rate Elastomeric Pumps
  • Continuous Rate Elastomeric Pumps
• Global Elastomeric Infusion Pumps Market, By Treatment
  • Pain management
  • Antibiotic/Antiviral
  • Chemotherapy
  • Others
• Global Elastomeric Infusion Pumps Market, By End User
  • Ambulatory Surgical Centers
  • Clinics
  • Home Care Settings
  • Hospitals
  • Others
• Global Elastomeric Infusion Pumps Market, By Region:
  • North America
    • By Country
      • U.S.
      • Canada
  • Latin America
    • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • By Country
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • By Region/Country
      • South Africa
      • Central Africa
      • North Africa
• Company Profiles
  • B. Braun Melsungen AG
  • Fresenius Kabi
  • Leventon, S.A.U
  • Ambu A/S
  • Baxter International Inc.
  • Halyard Health
  • Nipro Corporation